Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.

 

For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.

Show full CV Hide full CV

Latest news & insights

Blood samples
Life sciences & healthcare

Telehealth advertising admissible if accepted professional standards are observed

18 May 2022
Briefing

by Dr. Daniel Tietjen

Click here to find out more
chameleon skin
Life sciences & healthcare

TAMG – the new Veterinary Medicinal Products Act

18 May 2022
Briefing

by Dr. Daniel Tietjen

Click here to find out more
Life sciences & healthcare

Mandatory e-prescription rollout postponed

18 May 2022
Briefing

by Dr. Daniel Tietjen

Click here to find out more
Interface - FoodTech

The current regulatory framework for the marketing of products containing CBD

CBD in food and cosmetics: These requirements must be achieved for biscuits, muesli, soap and co. to be approved for the European internal market.

25 April 2022
Briefing

by Dr. Daniel Tietjen

3 of 4 Insights

Click here to find out more

Related people

Meet me at

There are no upcoming events